Xin Yang

Xin Yang

Auto-generated profile, based on publicly available information

Xin Yang

Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100070, Peoples R China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
LLLu Lu
Lu Lu
WXWeixi Xiong
Weixi Xiong
XYXin Yang
Xin Yang
XMXudong Ma
Xudong Ma
CWCaiyun Wang
Caiyun Wang
DZDong Zhou
Dong Zhou

3 June 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
YXYuzhu Xu
Yuzhu Xu
CLCuicui Liu
Cuicui Liu
QZQi Zhou
Qi Zhou
HGHongqiu Gu
Hongqiu Gu
YJYanan Jia
Yanan Jia
LGLi Guo
Li Guo
Background and objective: Our study aimed to evaluate the associations between platelet count (PC) and in-hospital outcomes for patients with stroke after rt-PA intravenous thrombolysis. Methods: We identified patients who had been hospitalized with a primary diagnosis of stroke and had received rt-PA intravenous thrombolysis from June 2015 to July 2019 at participating hospitals in the Chinese Stroke Center Alliance. PC measured before intravenous thrombolysis was categorized into the following four groups: severe thrombocytopenia (PC < 100 x 10(9)/L), mild thrombocytopenia (100 <= PC < 150 x 10(9)/L), normal PC (150 <= PC <= 450 x 10(9)/L), and thrombocythemia (PC > 450 x 10(9)/L). Outcomes were determined from clinical data collected during hospitalization. The primary clinical outcome was symptomatic intracranial hemorrhage (sICH). Secondary outcomes were mortality, bleeding events, gastrointestinal (GI) hemorrhage, and in-hospital stroke recurrence. We used multivariate logistic regression models to evaluate the associations between PC and outcomes. Results: We included 44,882 individuals with a median age of 66 years, of whom 34.7 % were female, 951 (2.1 %) had severe thrombocytopenia, 7218 (16.1 %) had mild thrombocytopenia, 36,522 (81.4 %) had a normal PC, and 191 (0.4 %) had thrombocythemia. Both severe and mild thrombocytopenia groups had higher risks of bleeding events (adjusted OR 1.30; 95 % CI,1.01-1.67; p = 0.045; adjusted OR 1.32; 95 % CI,1.19-1.46; p < 0.001) and sICH (adjusted OR 1.48;95 % CI,1.13-1.94; p = 0.005; adjusted OR 1.43;95 % CI,1.27-1.60; p < 0.001) than the normal PC group. Patients with 100 <= PC < 150 x 10(9)/L also had a higher risk of in-hospital stroke recurrence (adjusted OR 1.12; 95 % CI,1.02-1.22; p = 0.02). Conclusions: Intravenous thrombolysis brings a high risk of sICH given PC < 150 x 10(9)/L, especially PC < 100 x 10(9)/L. It indicated that PC < 100 x 10(9)/L is a reasonable contraindication to thrombolysis.

9 January 2024 in Epilepsy Research
Verified
Journal Article
Closed access
WXWeixi Xiong
Weixi Xiong
XYXin Yang
Xin Yang
LLLu Lu
Lu Lu
XMXudong Ma
Xudong Ma
CWCaiyun Wang
Caiyun Wang
DZDong Zhou
Dong Zhou